Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Testa

Showing results (101-110 of 187) with videos related to

Pageof 19
Sort By:
Cancer Research|January 1, 2016
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of CancerJill A Ohar, Mitchell Cheung, Jacqueline Talarchek, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitorYumiko Hirokawa, Anjali Tikoo, John Huynh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2008
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumorsChi Tarn, Lori Rink, Erin Merkel, et al.
American Journal of Respiratory Cell and Molecular Biology|September 18, 2007
HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathwayMaria E Ramos-Nino, Steven R Blumen, Tara Sabo-Attwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer modelSeiji Mabuchi, Deborah A Altomare, Mitchell Cheung, et al.
The Journal of Biological Chemistry|March 24, 2005
ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survivalZeng-qiang Yuan, Donghwa Kim, Satoshi Kaneko, et al.
Oncotarget|April 27, 2017
Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinomaWei Jiang, Essel Dulaimi, Karthik Devarajan, et al.
Pathology, Research and Practice|December 18, 2024
Tumor infiltrating T-cells and loss of expression of SWI/SNF genes in varying stages of clear cell renal cell carcinomaAlaa S Hrizat, Ruihe Lin, Jaime Eberle-Singh, et al.
The Journal of Biological Chemistry|November 9, 2016
ArgBP2γ interacts with Akt and p21-activated kinase-1 and promotes cell survivalZeng-Qiang Yuan, Donghwa Kim, Satoshi Kaneko, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM)Sai-Hong Ignatius Ou, James Moon, Linda L Garland, et al.
Pageof 19

Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
Cancer Research|January 1, 2016
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of CancerJill A Ohar, Mitchell Cheung, Jacqueline Talarchek, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitorYumiko Hirokawa, Anjali Tikoo, John Huynh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2008
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumorsChi Tarn, Lori Rink, Erin Merkel, et al.
American Journal of Respiratory Cell and Molecular Biology|September 18, 2007
HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathwayMaria E Ramos-Nino, Steven R Blumen, Tara Sabo-Attwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer modelSeiji Mabuchi, Deborah A Altomare, Mitchell Cheung, et al.
The Journal of Biological Chemistry|March 24, 2005
ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survivalZeng-qiang Yuan, Donghwa Kim, Satoshi Kaneko, et al.
Oncotarget|April 27, 2017
Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinomaWei Jiang, Essel Dulaimi, Karthik Devarajan, et al.
Pathology, Research and Practice|December 18, 2024
Tumor infiltrating T-cells and loss of expression of SWI/SNF genes in varying stages of clear cell renal cell carcinomaAlaa S Hrizat, Ruihe Lin, Jaime Eberle-Singh, et al.
The Journal of Biological Chemistry|November 9, 2016
ArgBP2γ interacts with Akt and p21-activated kinase-1 and promotes cell survivalZeng-Qiang Yuan, Donghwa Kim, Satoshi Kaneko, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM)Sai-Hong Ignatius Ou, James Moon, Linda L Garland, et al.
Pageof 19